The Role of Endocytic Pathways in TGF-β Signaling

Abstract

Transforming growth factor β (TGF-β) superfamily consists of numerous cytokins that regulate various cellular processes. TGF-β, the prototype of the family, signals through its cell surface serine/threonin kinase receptors and besides its role in cell differentiation, migration, adhesion etc. it is also able to induce epithelial-mesenchymal (EMT) transition via both Smad- pathway and MAPK- pathway. Among the different types of epithelial-mesenchymal transition, type II that is described to be associated with wound healing, tissue regeneration, organ fibrosis and is induced upon inflammatory stimuli. It can be triggered by secretion of growth factors such as TGF-β, EGF. Different endocytic routes are used for the internalization of TGF-β ligand and its receptors and these pathways can control the activity of downstream events. Internalization via clathrin-coated vesicles promotes the signaling while the caveola-mediated endocytosis plays important role in the termination of the events, although the steps of the latter event are less clear. The early endosome is considered a clue compartment in promoting the signaling. Recently published data suggest that the early endosome plays crucial role in the termination of the TGFβ signaling as well. It is not only maintain a special environment for the effective signaling but can direct the internalized cargos towards degradative pathways (multivesicular bodies, lysosomes).

RETRACTED ARTICLE: SDF-1/CXCR4 Axis Regulates Cell Cycle Progression and Epithelial-Mesenchymal Transition via Up-regulation of Survivin in Glioblastoma

“…Based on this definition, EMT is recognized as the occurrence of a variable proportion of tumor cells, which up-regulates mesenchymal markers such as vimentin, snail, and N-cadherin, and that down-regulates epithelial markers such as E-cadherin [8]. Several receptor tyrosine kinases induced EMT, such as the transforming growth factor β, which are associated with a more aggressive phenotype of cancer cells, which could be targeted to prevent tumor dissemination [9][10][11][12]. However, it is still unclear whether EMT was induced by chemokines and their receptors including the CXCR4 system.…”

Inhibition of Phosphate-Induced Vascular Smooth Muscle Cell Osteo-/Chondrogenic Signaling and Calcification by Bafilomycin A1 and Methylamine

“…Impaired acidification of endosomes could further disrupt receptor/ligand dissociation and interfere with TGFß1 receptor externalization [40,41]. How an alkalinization of the acidic cellular compartments affects the TGFB1 transcript levels, remains, however, elusive.…”

Hypoxia Suppresses TGF-B1-Induced Cardiac Myocyte Myofibroblast Transformation by Inhibiting Smad2/3 and Rhoa Signaling Pathways

“…TGF-β activates a heteromeric complex of type I and type II serine/threonine kinase receptors to induce phosphorylation of Smad2/3 transcription factors [13]. Phospho-Smad2/3 (p-Smad2/3) combines with commonly-expressed Smad4 and enters the nucleus to recruit the coactivator, CBP (CREB binding protein)/p300, to regulate downstream genes and alter ECM expression [14-16]. TGF-β can also activate mitogen-activated protein kinase (MAPK) signaling [17] and Ras homolog gene family, member A (RhoA) pathways [18] either independently or as modulators of Smads.…”